Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11269213 | 0.86 | SMN1; SMN2 (0.57) | SMN1; SMN2LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL11265685 | 0.83 | CYP1A2 (0.61) | SMN1; SMN2LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL11264089 | 0.80 | GAA (0.64) | SMN1; SMN2LMNAALDH1A1KMT2AMAPT | |
| SCHEMBL21156696 | 0.80 | EPHX2 (0.64) | SMN1; SMN2LMNAALDH1A1KMT2AHDAC3 | |
| SCHEMBL2420183 | 0.79 | CA2 (0.65) | ALDH1A1MAPTLDHA | |
| SCHEMBL11414289 | 0.77 | HDAC1 (0.65) | ALDH1A1KMT2AMEN1HDAC3HDAC1 | |
| SCHEMBL11414291 | 0.75 | HDAC1 (0.67) | SMN1; SMN2LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL11269139 | 0.74 | LMNA (0.56) | SMN1; SMN2LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL27118038 | 0.73 | CYP1A2 (0.57) | SMN1; SMN2LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL198282 | 0.73 | ALDH1A1 (0.62) | SMN1; SMN2LMNAALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4325964-A | SEDATIVES, MUSCLE RELAXANTS, HYPOTENSIVE AGENTS | LABORATOIRE L. LAFON (FR) | 1982-04-20 | — | — | US | claimed |
| US-4325964-A | SEDATIVES, MUSCLE RELAXANTS, HYPOTENSIVE AGENTS | LABORATOIRE L. LAFON (FR) | 1982-04-20 | — | — | US | disclosed |
| US-4225617-A | PSYCHOTROPIC AGENTS | LABORATOIRE L. LAFON (FR) | 1980-09-30 | — | — | US | disclosed |
| US-4209524-A | CENTRAL NERVOUS SYSTEM | LABORATOIRE L. LAFON (FR) | 1980-06-24 | — | — | US | disclosed |
| US-4209523-A | TREATMENT OF THE CENTRAL NERVOUS SYSTEM | LABORATOIRE L. LAFON (FR) | 1980-06-24 | — | — | US | disclosed |
| US-4183951-A | PSYCHOTROPIC AGENTS | LABORATOIRE L. LAFON (FR) | 1980-01-15 | — | — | US | disclosed |
| US-4152458-A | CENTRAL NERVOUS SYSTEM, PSYCHOTROPIC AGENTS | LABORATOIRE L. LAFON (FR) | 1979-05-01 | — | — | US | disclosed |
| US-4151300-A | CENTRAL NERVOUS SYSTEM, PSYCHOTROPIC | LABORATOIRE L. LAFON (FR) | 1979-04-24 | — | — | US | disclosed |
| US-4122186-A | PSYCHOTROPIC AGENTS | LABORATOIRE L. LAFON (FR) | 1978-10-24 | — | — | US | disclosed |